|
Journal Papers, Abstracts, and Commentaries
| |
Two,
three, and four-drug regimens for HIV post-exposure prophylaxis
in a North American sexual assault victim population.
Kumar T, Sampsel K, Stiell IG
Am J
Emerg Med. 2017 May 3
Abstract
A Qualitative Exploration of Sexual Assault
Patients' Barriers to Accessing and Completing HIV
Prophylaxis.
Djelaj V, Patterson D, Romero CM.
J Forensic Nurs.
2017 Apr/Jun;13(2):45-51
Abstract
Prescription of Post-Exposure Prophylaxis for
HIV-1 in the emergency room: Correct transmission risk
assessment remains challenging.
Marzel A, Heinrich H, Schilliger L, et al
J Acquir Immune Defic Syndr. 2016 Nov 30.
Abstract
FULL-TEXT ARTICLE
Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of
HIV Seroconversion in a Major North American Cohort.
Thomas R, Galanakis C, Vézina S,
et al
PLoS One.
2015 Nov 11;10(11):e0142534
Paper
Is postexposure prophylaxis with antiretroviral
therapy necessary in cases of blood exposure through a fight
when HIV-1 status is unknown?
Chéret A, Allemand J, Poggi C, et al
AIDS. 2014 Jan
2;28(1):137-9.
Abstract
Prescribing prophylaxis to patients who have been exposed to HIV.
Bagley S.
Emerg Nurse.
2012 Mar;19(10)
Abstract |
|
|
|
|
General Reports
Journal Papers, Abstracts, and Commentaries
| |
Starter packs versus full prescription of antiretroviral drugs
for postexposure prophylaxis: a systematic review.
Ford N, Venter F, Irvine C, Beanland RL, Shubber Z.
Clin Infect Dis. 2015 Jun 1;60
Suppl 3:S182-6.
Abstract
Optimizing adherence to preexposure and postexposure prophylaxis:
the need for an integrated biobehavioral approach.
Blashill AJ, Ehlinger PP, Mayer KH, Safren SA.
Clin Infect Dis.
2015 Jun 1;60 Suppl 3:S187-90.
Abstract
Choice of antiretroviral drugs for postexposure prophylaxis for
adults and adolescents: a systematic review.
Ford N, Shubber Z, Calmy A, et al
Clin Infect Dis. 2015 Jun
1;60 Suppl 3:S170-
Abstract |
|
Atazanavir-Based Regimens
Journal Papers, Abstracts, and
Commentaries
Darunavir-Based Regimens
Journal Papers, Abstracts, and
Commentaries
Conference Reports, Abstracts,
and Posters
Indinavir-Based Regimens
Journal Papers, Abstracts, and Commentaries
Lopinavir-Based Regimens
Journal Papers, Abstracts, and Commentaries
Nevirapine-Based Regimens
Journal Papers, Abstracts, and Commentaries
Raltegravir-Based
Regimens
Journal Papers, Abstracts, and Commentaries
| |
A randomized clinical trial comparing
ritonavir-boosted lopinavir versus raltegravir each with
tenofovir plus emtricitabine for post-exposure prophylaxis
for HIV infection.
Leal L, León A, Torres B, Inciarte A,
et al
J Antimicrob Chemother.
2016 Mar 18.
Abstract
Raltegravir-based HIV postexposure prophylaxis (PEP) in a real-life clinical
setting: fewer drug-drug interactions (DDIs) with improved adherence and
tolerability.
Mulka L, Annandale D, Richardson C,
et al
Sex Transm Infect. 2016
Mar;92(2):107. d
Abstract
Raltegravir, Tenofovir DF, and Emtricitabine for
Post-Exposure Prophylaxis to Prevent
the Sexual Transmission ofO
HIV: Safety, Tolerability, and Adherence.
Mayer KH, Mimiaga MJ, Gelman M, Grasso C
J Acquir Immune Defic Syndr.
2012 Jan 19
Abstract
Raltegravir-based post-exposure prophylaxis (PEP): a safe,
well-tolerated alternative regimen.
Annandale D, Richardson C, Fisher M, Richardson D.
J Int AIDS Soc.
2012 Nov 11;15(6):18165
Abstract
|
Zidovudine/Lamivudine-Based Regimens
Journal Papers, Abstracts, and Commentaries
|
General
Reports
HIV
PEP Main Page
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader